ST
Healthcare & Life Sciences
Syndesi Therapeutics
Belgium
Syndesi Therapeutics is a Healthcare & Life Sciences startup based in Belgium, most recent round Series A, 1 tracked investor.
series-a
series-a
Stage
1
Investors
About Syndesi Therapeutics
Syndesi Therapeutics is a startup based in Belgium. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Syndesi Therapeutics develops novel modulators of the synaptic vesicle protein SV2A based on research conducted at UCB, aiming to advance therapies for central nervous system disorders.
Explore Syndesi Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.